Chronic liver disease in the Alexandria governorate, Egypt: Contribution of schistosomiasis and hepatitis virus infections

Journal of Hepatology

Volumn 26, Issue 2, 1997, Pages 236-243

  Angelico, Mario ^a   Renganathan, Elil ^a   Gandin, Claudia ^a   Fathy, Moustafa ^e   Cristina Profili, M ^a   Rafai, Wael ^e   Santis, Adriano De ^b   Nagi, Ali ^e   Amin, Gamal ^e   Capocaccia, Livio ^b   Callea, Fracesco ^d   Rapicetta, Maria ^c   Badr, Gamal ^e   Rocchi, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Ospedale Civile   (Italy)

^e ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

cirrhosis; HBV; HCV; Schistosoma mansoni; virus hepatitis

Indexed keywords

ANTIBODY; ANTIGEN;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; EGYPT; GENOTYPE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0031047036     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80036-0     Document Type: Article

References (37)

1. Symmers WSC. Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia haematobia. J Pathol Bacteriol. 9:1904;237-239.
2. Dunn MA, Kamel R. Hepatic schistosomiasis. Hepatology. 1:1981;653-661.
3. De Cock KM. Hepatosplenic schistosomiasis: a clinical review. Gut. 27:1986;734-745.
4. Lyra LG, Reboucas G, Andrade ZA. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology. 71:1976;641-645.
5. Bassily S, Dunn MA, Farid Z, Kilpatrick ME, El-Masry NA, Kamel IA, El Alamy M, Murphy BL. Chronic hepatitis B in patients with Schistosomiasis mansoni. J Trop Med Hyg. 86:1983;67-71.
6. El-Hawey AM, Abdel-Rahman MM, Ibrahim MS, Abdel-Rahamn AH, Salama MMI. Delta virus versus HBsAg in chronic active hepatits and their relation to clinical, laboratory, and morbidity findings in bilharzial and non-bilharzial patients. J Egypt Soc Parasitol. 23:1993;151-160.
7. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet. 344:1994;1475-1479.
8. De Bac C, Stroffolini T, Gaeta GB, Taliana G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology. 20:1994;1225-1230.
9. Saeed AA, Al-Admawi AM, Al-Rasheed A, Fairclough D, Bacchus R, Ring C, Garson J. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet. ii:1991;459-460.
10. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD. High HCV prevalence in Egyptian blood donors. Lancet. 340:1992;427.
11. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg. 49:1993;440-447.
12. Hassan NF. Prevalence of hepatitis C antibodies in patient groups in Egypt. Trans R Soc Trop Med Hyg. 87:1993;638.
13. Farghaly AG, Barakat RM. Prevalence, impact and risk factors of hepatitis C infection. Publ Health Assoc. LXVIII:1993;63-79.
14. Dusheiko G, Schimilovitz-Weiss H, Brown D, McOmish F, Pong-Lee Yap, Sherlock S, McIntryre N, Simmonds P. Hepatiis C virus genotypes: an investigation of type-specific difference in geographic origin and disease. Hepatology. 19:1994;13-18.
15. Koshy A, Al-Nakib B, Al-Mufti S, Madda SP, Hira PR. Anti-HCV-positive cirrhosis associated with Schistosomiasis. Am J Gastroenterol. 88:1993;1428-1431.
16. AbdelWahab MF, Zakaria S, Kamel M, Abdel-Khaliq MK, Mabrouk MA, Salama H, Esmat G, Thomas GL, Strickland GT. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg. 51:1994;563-567.
17. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT. High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut. 37:1995;105-107.
18. Cairo, Egypt Cairo WHO Workshop on Ultrasonography in schistosomiasis. Proposal for a practical guide to the standardized use of ultrasound in the assessment of pathological changes. WHO Bull. 1-4 October 1990;1-31. TDR/SCH/ULTRASIN 91.3.
19. Xue CG, Taylor MG, Bickle QD, Savioli L, Renganathan EA. Diagnosis of Schistosoma haematobium infection: evaluation of ELISA using keyhole limpet haemocyanin or soluble egg antigen in comparison with detection of eggs or haematuria. Trans R Soc Trop Med Hyg. 87:1993;654-658.
20. Rapicetta M, Attili AF, Mele A, De Santis A, Chionne P, Cristiano K, Spada E, Giuliani E, Carli L, Goffredo F, Capocaccia L. Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population. J Med Virol. 37:1992;87-92.
21. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Hzuka H, Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 74:1993;2385-2390.
22. Stuyver L, Rassau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C isolates and characterization of new. J Gen Virol. 74:1993;1093-1102.
23. Katz N, Chaves A, Pellegrino J. A simple device for quantitive stool thick-smear technique in Schistosomiasis mansoni. 14:1972;397-400. Revista do Instituto de Medicina Tropical de Sao Paulo.
24. Disease of the Liver. Standardization of Nomenclature, Diagnostic Criteria and Prognosis. 1994;Raven Press, New York.
25. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
26. Prakash S, Postlehwaite AE, Wuler DJ. Alterations in influence of granuloma-derived cytokines on fibrogenesis in the course of murine Schistosoma mansoni infection. Hepatology. 13:1991;970-976.
27. Boros DL, Lelley RP, Warren KS. Spontaneous modulation of granulomatous hypersensitivity in Schistosoma mansoni. J Immunol. 114:1975;1437-1441.
28. Andrade ZA, Peixoto E, Guerret SV, Grimaud J-A. Hepatic connective tissue changes in hepatosplenic schistosomiasis. Hum Pathol. 23:1992;566-572.
29. Khalifa AS, Mitchell BS, Watts DM, El-Samathy MH, El-Sayed MH, Hassan NF, Jennings GB, Hibbs RG, Corwin AL. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. Am J Trop Med Hyg. 49:1993;316-321.
30. Hyams KC, Mansour MM, Massoud A, Dunn MA. Parenteral antischistosomal therapy: a potential risk factor for hepatitis B infection. J Med Virol. 23:1987;109-114.
31. Brechot C. Hepatitis C virus genetic variability: clinical implications. Am J Gastroenterol. 89:1994;S41-47.
32. Gordon SC, Elloway RS, Long JC, Muchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use. Hepatology. 18:1993;1338-1343.
33. Colombo M, De Franchis R, Del Ninno E, Sangiovani A, De Fazio C, Tommasini M, Donato MF, Piva A, Dicarlo V, Dioguardi N. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:1991;675-680.
34. Warren KS, Rosenthal MS, Domingo EO. Mouse hepatitis virus (MHV3) infection in chronic murine Schistosomiasis mansoni. Bull NY Acad Med. 45:1969;211-224.
35. 1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA. 90:1993;948-952.
36. Pons HA, Morgan JS, Hutchinson ML, Rojkind M, Groszmann RJ, Stadecker MJ. Resistance to reinfection in experimental murine schistosomiasis: role of porto-hepatic hemo-dynamics. Am J Trop Med Hyg. 41:1989;189-197.
37. Wilson RA. Leaky livers, portal shunting and immunity to schistosomes. Parasitology Today. 6:1990;354-358.